Northwest Biotherapeutics completes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 8/9/13 Type: Direct public offering Raised: $15 million Units: 4.5 million Price: $3.35 (unit) Shares after...